Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Rapid deployment surgical valves linked to higher rates of stroke, pacemaker implantation

Sutureless valves have recently been developed to streamline surgical aortic valve replacement (SAVR) procedures, with the hope that shorter operations lead to better outcomes. But a new study in the Journal of the American College of Cardiology suggests quicker is not always better.

Thumbnail

Can social isolation, loneliness be associated with cardiovascular disease?

Socially isolated and lonely individuals face increased risk for acute myocardial infarction (AMI) and stroke compared to those with personal networks, according to new research published online March 27 in Heart. Those with a history of AMI and stroke are also at an increased risk for death.

Thumbnail

Door-to-diuretic time has little impact on mortality for acute heart failure patients

The speed with which IV diuretics were administered to people with acute heart failure (AHF) didn’t appear to make a difference in short- or intermediate-term mortality rates, according to a study of 2,761 Korean patients.

Thumbnail

Abiomed appoints Todd A. Trapp as new CFO

Todd A. Trapp will take over as CFO of Abiomed on April 9, the company announced March 30.

AFib after CABG linked to minimal long-term stroke risk

Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.

Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor

ABBOTT PARK, Ill., March 29, 2018 — Abbott (NYSE: ABT) announced today the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS™ HF System. The GUIDE-HF trial will study whether the CardioMEMS device can improve survival and quality of life for people living with New York Heart Association (NYHA) Class II – IV heart failure.

Thumbnail

YMCA, AHA team up to fight high blood pressure

The YMCA and American Heart Association (AHA) are launching a collaborative effort this spring to help combat hypertension. Through the new partnership, clinics participating in the AHA and American Medical Association’s national Target: BP initiative can refer patients to the YMCA for free support in learning how to self-monitor their blood pressure.

Thumbnail

30% of bioprosthetic SAVR patients show valve degeneration within a decade

Bioprosthetic heart valves used in surgical aortic valve replacement (SAVR) procedures in the early 2000s demonstrated “satisfactory” durability, according to a single-center study published in the Journal of the American College of Cardiology.